Simultaneously target of normal and stem cells-like gastric cancer cells via cisplatin and anti-CD133 CAR-T combination therapy
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Simultaneously target of normal and stem cells-like gastric cancer cells via cisplatin and anti-CD133 CAR-T combination therapy
Authors
Keywords
-
Journal
CANCER IMMUNOLOGY IMMUNOTHERAPY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-02-27
DOI
10.1007/s00262-021-02891-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Autophagy induced by Helicobacter pylori infection is necessary for gastric cancer stem cell emergence
- (2020) Sarah Courtois et al. Gastric Cancer
- Targeting Liver Cancer Stem Cells: An Alternative Therapeutic Approach for Liver Cancer
- (2020) Hwa-Yong Lee et al. Cancers
- The Role of HER2 in Self-Renewal, Invasion, and Tumorigenicity of Gastric Cancer Stem Cells
- (2020) Li-Fei Sun et al. Frontiers in Oncology
- Gastric Stem Cells: Physiological and Pathological Perspectives
- (2020) Shiyu Xiao et al. Frontiers in Cell and Developmental Biology
- Expression of ALDH1A1 and CD133 is associated with the prognosis and effect of different chemotherapeutic regimens in gastric cancer
- (2019) Wan‑Ting Liu et al. Oncology Letters
- Development of NKG2D-based chimeric antigen receptor-T cells for gastric cancer treatment
- (2018) Kelong Tao et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Cisplatin triggers cancer stem cell enrichment in platinum-resistant cells through NF-κB-TNFα-PIK3CA loop
- (2017) Bhushan Thakur et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Cisplatin resistance in gastric cancer cells is associated with HER2 upregulation-induced epithelial-mesenchymal transition
- (2016) Dongsheng Huang et al. Scientific Reports
- CD133 overexpression correlates with clinicopathological features of gastric cancer patients and its impact on survival: a systematic review and meta-analysis
- (2015) Li Yiming et al. Oncotarget
- Overcoming Multidrug Resistance in Cancer Stem Cells
- (2015) Karobi Moitra Biomed Research International
- Cisplatin in cancer therapy: Molecular mechanisms of action
- (2014) Shaloam Dasari et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Expression of CD133 in the cytoplasm is associated with cancer progression and poor prognosis in gastric cancer
- (2013) Kousuke Hashimoto et al. Gastric Cancer
- Prognostic Value of Cancer Stem Cell Marker CD133 Expression in Gastric Cancer: A Systematic Review
- (2013) Lei Wen et al. PLoS One
- Isolation, identification and expression of specific human CD133 antibodies
- (2013) Jing Xia et al. Scientific Reports
- Cisplatin Selects for Multidrug-Resistant CD133+ Cells in Lung Adenocarcinoma by Activating Notch Signaling
- (2012) Y.-P. Liu et al. CANCER RESEARCH
- CD133 and CD44 Cell surface markers do not identify cancer stem cells in primary human gastric tumors
- (2011) Alba Rocco et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More